Toshiba Medical Systems Europe BV

+31/3689222http://www.toshiba-europe.com/medical

Request Information
Categories:X-ray imaging

Toshiba introduces “SURESubtraction Coronary” at ESC 2014

Visualization of the coronary lumen is improved by very advanced subtraction software. This represents a major step forward in diagnosing coronary artery disease in patients with severe calcium or stents for whom Cardiac CT Angiography was not recommended.

Zoetermeer, The Netherlands, August 11, 2014 – Visualization of the coronary lumen is improved by very advanced subtraction software. This represents a major step forward in diagnosing coronary artery disease in patients with severe calcium or stents for whom Cardiac CT Angiography was not recommended.

Toshiba is proud to introduce “SURESubtraction™ Coronary”. This software was developed in close cooperation with the Iwate Medical University in Japan, leading hospitals in the USA and Europe and the European based research center, Toshiba Medical Visualization Systems.

Severe coronary calcification influences the effectiveness of Coronary CT Angiography in ruling out coronary artery disease. Frequently these patients are referred for invasive angiography because of clinical suspicion of significant coronary artery disease. Stents placed in the coronary arteries can make visualization of the lumen within the stent difficult, hindering the ability to diagnose in-stent restenosis.

SURESubtraction Coronary” removes calcification and stents from the coronary arteries, therefore improving visualization of the coronary lumen. Blooming effects caused by calcification are dramatically reduced.

An added benefit of “SURESubtraction Coronary” is that it can be obtained with a near dose neutral scanning protocol. Coronary Subtraction is performed by subtracting a routine Calcium Score dataset from a Coronary CT Angiography dataset. The Calcium Score scan being used as the non-contrast mask for subtraction.

Atlas based cardiac segmentation and sophisticated rigid and deformable registration algorithms enable accurate subtraction of the coronary arteries to become a reality, leading to improved visualization of the coronary lumen.

The unique capabilities of the wide area detector Aquilion ONETM series are a perfect platform for this ground-breaking new development.

The 16cm z-axis coverage of the Aquilion ONE series allows imaging of the heart in just one rotation, ensuring the scan is performed at the same moment in time, making the registration and subtraction process as simple as possible.

Toshiba Seminar and Workshops at ESC

In order to become familiar with this new technology, Toshiba invites ESC participants to join a Satellite Lunch Symposium, on Sunday, August 31, 2014 from 12.45 – 13.45 hrs.

The opportunity to gain an in-depth knowledge of “Coronary Subtraction” will be available for participants subscribing to Toshiba’s “Hands-on Workshops”. These workshops will cover a wide range of advanced imaging techniques, presented by leading European specialists. More details on these workshops and registration can be found on http://www.toshiba-medical.eu/eu/events/esc-2014-workshop-registration

- See more at: http://www.toshiba-medical.eu/eu/toshiba-introduces-suresubtraction-coronary-at-esc-2014/#sthash.UvCvHORq.dpufZoetermeer, The Netherlands, August 11, 2014 – Visualization of the coronary lumen is improved by very advanced subtraction software. This represents a major step forward in diagnosing coronary artery disease in patients with severe calcium or stents for whom Cardiac CT Angiography was not recommended.Severe coronary calcification influences the effectiveness of Coronary CT Angiography in ruling out coronary artery disease. Frequently these patients are referred for invasive angiography because of clinical suspicion of significant coronary artery disease. Stents placed in the coronary arteries can make visualization of the lumen within the stent difficult, hindering the ability to diagnose in-stent restenosis.
Zoetermeer, The Netherlands, August 11, 2014 – Visualization of the coronary lumen is improved by very advanced subtraction software. This represents a major step forward in diagnosing coronary artery disease in patients with severe calcium or stents for whom Cardiac CT Angiography was not recommended. - See more at: http://www.toshiba-medical.eu/eu/toshiba-introduces-suresubtraction-coronary-at-esc-2014/#sthash.UvCvHORq.dpuf

Zoetermeer, The Netherlands, August 11, 2014

Toshiba is proud to introduce “SURESubtraction™ Coronary”. This software was developed in close cooperation with the Iwate Medical University in Japan, leading hospitals in the USA and Europe and the European based research center, Toshiba Medical Visualization Systems.

Severe coronary calcification influences the effectiveness of Coronary CT Angiography in ruling out coronary artery disease. Frequently these patients are referred for invasive angiography because of clinical suspicion of significant coronary artery disease. Stents placed in the coronary arteries can make visualization of the lumen within the stent difficult, hindering the ability to diagnose in-stent restenosis.

“SURESubtraction Coronary” removes calcification and stents from the coronary arteries, therefore improving visualization of the coronary lumen. Blooming effects caused by calcification are dramatically reduced.

An added benefit of “SURESubtraction Coronary” is that it can be obtained with a near dose neutral scanning protocol. Coronary Subtraction is performed by subtracting a routine Calcium Score dataset from a Coronary CT Angiography dataset. The Calcium Score scan being used as the non-contrast mask for subtraction.

Atlas based cardiac segmentation and sophisticated rigid and deformable registration algorithms enable accurate subtraction of the coronary arteries to become a reality, leading to improved visualization of the coronary lumen.

The unique capabilities of the wide area detector Aquilion ONETM series are a perfect platform for this ground-breaking new development.

The 16cm z-axis coverage of the Aquilion ONE series allows imaging of the heart in just one rotation, ensuring the scan is performed at the same moment in time, making the registration and subtraction process as simple as possible.

Toshiba Seminar and Workshops at ESC

In order to become familiar with this new technology, Toshiba invites ESC participants to join a Satellite Lunch Symposium, on Sunday, August 31, 2014 from 12.45 – 13.45 hrs.

The opportunity to gain an in-depth knowledge of “Coronary Subtraction” will be available for participants subscribing to Toshiba’s “Hands-on Workshops”. These workshops will cover a wide range of advanced imaging techniques, presented by leading European specialists. More details on these workshops and registration can be found on http://www.toshiba-medical.eu/eu/events/esc-2014-workshop-registration

Relevant publication

R. Tanaka, K. Yoshioka, K. Muranaka, T. Shiba, T. Ueda, T. Sasaki, T. Fusazaki, S. Ehara, “Improved evaluation of calcified segments on coronary CTA: a feasibility study of coronary calcium subtraction”, Int J Cardiovasc Imaging, 2013 Dec;29 Suppl 2:75-81

Aquilion ONE and SURESubtraction are trademarks of Toshiba Medical Systems Corporation.

About Toshiba Medical Systems Europe BV

With headquarters in Zoetermeer, The Netherlands, Toshiba Medical Systems Europe BV markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in Europe. For more information please visit www.toshiba-medical.eu

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly-owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s web site at http://www.toshibamedicalsystems.com/

About Toshiba

Toshiba Corporation, a Fortune Global 500 company, channels world-class capabilities in advanced electronic and electrical product and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services.

Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future”, Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation”, and is contributing to the achievement of a world in which people everywhere live in safe, secure and comfortable society.

Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm